THPMX
Price
$15.05
Change
+$0.06 (+0.40%)
Updated
Sep 26 closing price
Net Assets
53.67M
VIMSX
Price
$79.84
Change
+$0.88 (+1.11%)
Updated
Sep 26 closing price
Net Assets
199.16B
Interact to see
Advertisement

THPMX vs VIMSX

Header iconTHPMX vs VIMSX Comparison
Open Charts THPMX vs VIMSXBanner chart's image
Thompson MidCap
Price$15.05
Change+$0.06 (+0.40%)
VolumeN/A
Net Assets53.67M
Vanguard Mid Cap Index Investor
Price$79.84
Change+$0.88 (+1.11%)
VolumeN/A
Net Assets199.16B
THPMX vs VIMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
THPMX vs. VIMSX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is THPMX is a Buy and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 199B vs. THPMX (53.7M). VIMSX pays higher dividends than THPMX: VIMSX (1.35) vs THPMX (0.52). THPMX was incepted earlier than VIMSX: THPMX (18 years) vs VIMSX (27 years). THPMX (1.38) is less costly to investors than VIMSX (0.17). THPMX is a more actively managed with annual turnover of: 27.00 vs. VIMSX (16.00). THPMX has a lower initial minimum investment than VIMSX: THPMX (250) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 11.57 vs. THPMX (6.36). VIMSX return over 5 years is better than : 70.75 vs. THPMX (47.33).
THPMXVIMSXTHPMX / VIMSX
Total Expense Ratio1.150.17676%
Annual Report Gross Expense Ratio1.380.17812%
Fund Existence18 years27 years-
Gain YTD12.14610.845112%
Front LoadN/AN/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets53.7M199B0%
Annual Yield % from dividends0.521.3538%
Returns for 1 year6.3611.5755%
Returns for 3 years22.7755.7441%
Returns for 5 years47.3370.7567%
Returns for 10 years38.75160.6624%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LXRX1.400.06
+4.48%
Lexicon Pharmaceuticals
APGE38.220.70
+1.87%
Apogee Therapeutics
ASTS49.09-0.30
-0.61%
AST SpaceMobile
JDZG1.81-0.02
-1.09%
Jiade Limited
LIDR2.36-0.03
-1.26%
AEye